IP Library Granted Patent US 12708698
Granted Patent B2
US 12708698 · App. 17/996,399 · Granted Aug 18, 2026

Formulation comprising a phosphocalcic cement and a physical and/or covalent hydrogel of polysaccharides, printable and having ductile mechanical properties for bone regeneration/bone repair

Inventors: Marie-Michèle Germaini (Nantes, FR); Pierre Weiss (Nantes, FR); Pierre Corre (Montbert, FR); Hélène Gautier (Les Sorinieres, FR)
Assignees: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM); Nantes Université; CHU Nantes
A61L27/3847A61L27/20A61L27/46A61L27/52A61L27/54
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12708698
App. No.
17/996,399
Granted
Aug 18, 2026
Kind
B2
Abstract

The present invention relates to the use of a formulation comprising a phosphocalcic cement and a physical and/or covalent hydrogel of polysaccharides for 3D printing, more particularly for bone regeneration and/or bone repair. The present invention also relates to a kit for 3D printing of bone implants comprising a phosphocalcic cement and a physical and/or covalent hydrogel of polysaccharides as well as to a method to prepare a formulation for 3D printing comprising a step of mixing a phosphocalcic cement and a physical and/or covalent liquid hydrogel precursor of polysaccharides.

Claims (25)

1 . A method for 3D printing comprising the step of printing a formulation comprising a phosphocalcic cement and a physical and/or covalent hydrogel of polysaccharides.

2 . The method according to claim 1 , wherein said polysaccharides are hyaluronic acid and/or chitosan.

3 . The method according to claim 1 , wherein said hydrogel is a physical hydrogel.

4 . The method according to claim 1 , wherein said cement is a tricalcium phosphate cement.

5 . The method according to claim 1 , wherein the ratio hydrogel/cement is of 2:3 w/w.

6 . The method according to claim 1 , wherein said hydrogel is a physical hydrogel comprising from 2 to 4% w/v of hyaluronic acid and/or chitosan.

7 . The method according to claim 1 , wherein said hydrogel is a covalent hydrogel of silated hyaluronic acid and/or silated chitosan.

8 . The method according to claim 1 , for bone regeneration and/or bone repair.

9 . The method according to claim 1 in the context of vertical bone augmentation, complex geometries, large critical size bone defects, or following congenital diseases or to fill bone defects following tumor resections.

10 . The method according to claim 1 for 3D printing of bone implants.

11 . The method according to claim 1 , wherein the phosphocalcic cement is prepared with α-TCP.

12 . A kit for 3D printing of bone implants comprising:

(i) a phosphocalcic cement; and

(ii) a physical and/or covalent hydrogel of polysaccharides.

13 . A method to prepare a formulation for 3D printing comprising a step of mixing a phosphocalcic cement and a physical and/or covalent liquid hydrogel precursor of polysaccharides.

14 . An implant comprising a formulation as defined in claim 1 .

15 . Implant according to claim 14 , further comprising active molecules.

16 . The implant according to claim 14 , further comprising growth factors and/or cells.

17 . A method for bone repair and/or bone regeneration comprising:

(i) preparing a formulation comprising a phosphocalcic cement and a physical and/or covalent hydrogel of polysaccharides/or chitosan;

(ii) 3D printing of said formulation to form an implant; and optionally

(iii) inserting the implant obtained further to step (ii) in a bone cavity.

18 . A method according to claim 17 , wherein the cement and the hydrogel are sterilized in a sterile environment or wherein the implant is sterilized before insertion.

19 . The method for bone repair and/or bone regeneration according to claim 17 , comprising preparing a formulation comprising α-TCP powder, and a physical and/or covalent hydrogel of polysaccharides as in step (i).

20 . The method according to claim 17 , wherein the hydrogel comprises hyaluronic acid and/or chitosan.